These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 2663144
1. Elimination of malignant clonogenic breast cancer cells from human bone marrow. Anderson IC, Shpall EJ, Leslie DS, Nustad K, Ugelstad J, Peters WP, Bast RC. Cancer Res; 1989 Aug 15; 49(16):4659-64. PubMed ID: 2663144 [Abstract] [Full Text] [Related]
2. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Shpall EJ, Bast RC, Joines WT, Jones RB, Anderson I, Johnston C, Eggleston S, Tepperberg M, Edwards S, Peters WP. Bone Marrow Transplant; 1991 Feb 15; 7(2):145-51. PubMed ID: 2049558 [Abstract] [Full Text] [Related]
3. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres. O'Briant KC, Shpall EJ, Houston LL, Peters WP, Bast RC. Cancer; 1991 Sep 15; 68(6):1272-8. PubMed ID: 1873781 [Abstract] [Full Text] [Related]
4. Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement. Haleem A, Kurtzberg J, Olsen GA, Rhinehardt-Clark A, Leslie DS, Ray L, Smith CA, Peters WP, Haynes BF, Bast RC. Cancer Res; 1987 Sep 01; 47(17):4608-12. PubMed ID: 3113721 [Abstract] [Full Text] [Related]
5. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts. Humblet Y, Feyens AM, Sekhavat M, Agaliotis D, Canon JL, Symann ML. Cancer Res; 1989 Sep 15; 49(18):5058-61. PubMed ID: 2548708 [Abstract] [Full Text] [Related]
6. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC. Cancer Res; 1986 Mar 15; 46(3):1208-13. PubMed ID: 3510720 [Abstract] [Full Text] [Related]
9. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads. Vredenburgh JJ, Simpson W, Memoli VA, Ball ED. Cancer Res; 1991 May 01; 51(9):2451-5. PubMed ID: 1673088 [Abstract] [Full Text] [Related]
10. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin. Montgomery RB, Kurtzberg J, Rhinehardt-Clark A, Haleen A, Ramakrishnan S, Olsen GA, Peters WP, Smith CA, Haynes BF, Houston LL. Bone Marrow Transplant; 1990 Jun 01; 5(6):395-402. PubMed ID: 2369680 [Abstract] [Full Text] [Related]
12. Purging breast cancer cells in preparation for autologous bone marrow transplantation. Morecki S, Pavlotzky F, Margel S, Slavin S. Bone Marrow Transplant; 1987 Apr 01; 1(4):357-63. PubMed ID: 3332143 [Abstract] [Full Text] [Related]
16. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer. Coombes RC, Buckman R, Forrester JA, Shepherd V, O'Hare MJ, Vincent M, Powles TJ, Neville AM. Cancer Res; 1986 Aug 01; 46(8):4217-20. PubMed ID: 3524802 [Abstract] [Full Text] [Related]
19. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. Shpall EJ, Anderson IC, Bast RC, Joines WT, Jones RB, Ross M, Edwards S, Eggleston S, Johnston C, Tepperberg M. Prog Clin Biol Res; 1990 Aug 01; 333():321-35; discussion 336. PubMed ID: 2308989 [No Abstract] [Full Text] [Related]